CytoSolve collaborates With world-renowned scientists at leading Universities, Research Institutions and Foundations to develop and Systems Architecture and Models of diseases to produce patented formulations that will improve lives.
AI-Driven Peptide Design. Building the world's most advanced generative AI platform for peptide therapeutics.
The Weizmann Institute of Science is one of the world’s leading multidisciplinary basic research institutions in the natural and exact sciences.
For more than 125 years, the University of Chicago has forged its own path. This has led to new schools of thought and a transformative education for students, and laid the groundwork for breakthroughs across the sciences, medicine, economics, law, business, history, culture, the arts, and humanistic inquiry.
Nuvogenix has an extensive R&D pipeline of medial and natural formulations.
Nuvogenix companies have published some of the most ground-breaking papers and achieved high levels of citiations.